New drug cocktail shows promise for tough lymphoma cases
Disease control
Ongoing
This early-phase study tests a combination of three drugs (obinutuzumab, venetoclax, and lenalidomide) in 22 adults with B-cell non-Hodgkin lymphoma that has come back or stopped responding to prior treatments. The main goal is to find the safest dose and identify side effects. R…
Phase: PHASE1 • Sponsor: Beth Christian • Aim: Disease control
Last updated Apr 29, 2026 07:11 UTC